Literature DB >> 23567390

The association of selective serotonin reuptake inhibitors use and stroke in geriatric population.

Chia-Chun Hung1, Ching-Heng Lin, Tsuo-Hung Lan, Chin-Hong Chan.   

Abstract

OBJECTIVES: Selective serotonin reuptake inhibitor (SSRI) exposure has controversial results in increasing the stroke risk. With the risk of stroke increased with age, the safety of SSRI use among older adults attracts much concern.
METHODS: We analyzed 28,145 subjects older than 65 years from a subset of a 9-year cohort database from the National Health Insurance Research Database, Taiwan.
RESULTS: The survival analysis showed a greater probability of stroke in subjects with SSRI exposure after adjusting other covariates. Compared with other variables, SSRI exposure had the strongest effect (hazard ratio: 2.66, 95% confidence interval: 2.21-3.20). The risk was independent to depression-related stroke risk.
CONCLUSIONS: The use of SSRIs independently increases the risk of stroke among older patients. SSRIs are still practically safe to most users, providing precautionary measures are taken.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Geriatric; hemorrhage; ischemia; selective serotonin reuptake inhibitors (SSRIs); stroke

Mesh:

Substances:

Year:  2013        PMID: 23567390     DOI: 10.1016/j.jagp.2013.01.018

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  9 in total

1.  Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

Authors:  Seung-Won Oh; Joonseok Kim; Seung-Kwon Myung; Seung-Sik Hwang; Dae-Hyun Yoon
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

2.  Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome.

Authors:  Li Liu; Matthew Fuller; Tyler P Behymer; Yisi Ng; Thomas Christianson; Shreyansh Shah; Nicolas Kon Kam King; Daniel Woo; Michael L James
Journal:  Stroke       Date:  2020-03-04       Impact factor: 7.914

3.  Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury.

Authors:  Bilal Khokhar; Linda Simoni-Wastila; Jennifer S Albrecht
Journal:  J Head Trauma Rehabil       Date:  2017 Jan/Feb       Impact factor: 2.710

Review 4.  Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.

Authors:  Doosup Shin; Yun Hwan Oh; Chun-Sick Eom; Sang Min Park
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

5.  The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis.

Authors:  Melanie P Jensen; Oliver J Ziff; Gargi Banerjee; Gareth Ambler; David J Werring
Journal:  Eur Stroke J       Date:  2019-01-25

6.  SSRI co-medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010-2015.

Authors:  Safoura Sheikh Rezaei; Martina Mittlböck; Bertholdt Reichardt; Michael Wolzt
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-24       Impact factor: 3.485

Review 7.  Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies.

Authors:  David Taylor; Anna Sparshatt; Seema Varma; Olubanke Olofinjana
Journal:  BMJ       Date:  2014-03-19

8.  Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.

Authors:  Carol Coupland; Trevor Hill; Richard Morriss; Michael Moore; Antony Arthur; Julia Hippisley-Cox
Journal:  BMJ       Date:  2016-03-22

9.  Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.

Authors:  Che-Sheng Chu; Po-Han Chou; Ching-Heng Lin; Chin Cheng; Chia-Jui Tsai; Tsuo-Hung Lan; Min-Wei Huang; Gerald Nestadt
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.